Search

Kathryn Ann Grenier

from Bend, OR
Age ~69
Get Report
Also known as:
Kathryn A Grenier, Kathryn Grenier Cardott, Kathryn A Cardott, Kathryn G Cardott, Kathryn T, Kathryn Grenier N, Kathryn Grenier Card, Kathy Cardott
Related to:
Mary P Murray, 64Linda K Cardott, 69Dolores CardottJohn N Cardott, 69Dorles Cardott, 90Dolores H CardottJessica D Cardott, 47
Connected to:
Amie A Grenier, 53Angela M Grenier, 55Anita A Grenier, 75Antoine Grenier, 52Candace A Grenier, 44Carolyn T Grenier, 81Cathy C Grenier, 58Celeste C Grenier, 66Chantal L Grenier, 34Chelsie T Grenier, 28

Kathryn Grenier Phones & Addresses

  • Bend, OR
  • Tucson, AZ
  • Los Gatos, CA
  • Morgan Hill, CA
  • Cupertino, CA
  • Hollister, CA
  • Santa Clara, CA

Work

Company: Amplimed corporation Position: Vp clinical operations

Industries

Pharmaceuticals

Resumes

Resumes

Kathryn Grenier Photo 1

Kathryn Grenier

View page
Location:
Tucson, AZ
Industry:
Pharmaceuticals
Work:
AmpliMed Corporation
VP Clinical Operations

Business Records

Name / Title
Company / Classification
Phones & Addresses
Kathryn Grenier
Vice-President
Amplimed Corporation
Commercial Physical Research · Research & Development in Biotechnology
4380 N Campbell Ave, Tucson, AZ 85718
4280 N Campbell Ave, Tucson, AZ 85718
(520) 529-1000, (520) 529-3001

Publications

Us Patents

Methods Of Treating Concomitant Constipation In A Cancer Treatment Regimen Including Imexon

View page
US Patent:
20070048250, Mar 1, 2007
Filed:
Aug 29, 2006
Appl. No.:
11/512998
Inventors:
Evan Hersh - Tucson AZ, US
Kathryn Grenier - Tucson AZ, US
Assignee:
AmpliMed Corporation - Tucson AZ
International Classification:
A61K 31/715
A61K 31/7072
A61K 31/337
US Classification:
424078300, 514054000, 514049000, 514449000
Abstract:
Methods of treating imexon-induced constipation in patients in conjunction with their participation in a cancer treatment regimen are disclosed herein. Embodiments of the invention include the treatment of imexon-induced constipation arising from the administration of imexon alone or in combination with other chemotherapeutic agents. Also disclosed are pharmaceutical compositions and pharmaceutical kits comprising a therapeutically effective amount of imexon and an amount of a laxative effective in treating imexon-induced constipation. Embodiments of the present invention include prophylactic anticonstipation regimens comprising one or more laxatives that may be prescribed and/or administered prior to or during the course of treatment of the patient with imexon.
Control profile
Kathryn Ann Grenier from Bend, OR, age ~69 Get Report